ArticleInternational journal of clinical oncology2019
Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.
Keisuke Shigeta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.